Vishay (VSH) Q3 2026 Earnings Call Transcript

Vishay Intertechnology reported record Q3 2026 revenue of $979 million, up 24% year over year and above its $945 million–$975 million guidance range; non-GAAP EPS was $0.37 versus $0.04 a year earlier. Gross margin rose 600 basis points year over year to 25.5%, with a 1.29 book-to-bill ratio and $2.2 billion backlog; management guided Q4 revenue to $975 million–$1.005 billion and gross margin to 25.5%–26.5%. AI-related revenue is targeted at approximately $200 million in 2026, while full-year capex guidance was reduced to $350 million–$400 million because of equipment delivery delays, and free cash flow is expected to be approximately break-even for the year.

Analysis

VSH’s more durable upside is not simply AI exposure: wider distribution availability and more components designed into the same power systems can lift share and factory utilization across industrial applications. That creates operating leverage if volumes hold, but the reported order strength is not yet proof of end-demand durability: extended customer coverage and distributors unable to rebuild stock can amplify bookings ahead of consumption. The key check is whether point-of-sale growth stays strong while channel inventory remains disciplined.

Near term, pricing and mix are supporting margin recovery, but that leverage cuts both ways. If demand normalizes before delayed equipment arrives, the company could be left with investment and inventory ahead of utilization; if supply remains tight, competitors with weaker delivery performance may cede share. The Germany fab’s delayed ramp limits near-term capacity relief, while the planned 2027 production start means execution benefits are still prospective. Quarterly cash generation also overstates full-year conversion: reducing receivables financing and continued investment leave little room to infer a sustainably higher FCF run rate. Elevated taxes further mute EPS conversion.

Contrarian read: the structural-share-gain story may be real, but management’s attribution is not independently quantified against cycle and customer stocking. The upside case is underwritten by POS, pricing and margin follow-through—not backlog alone. Over the next 1–3 months, watch Q4 delivery, gross margin and channel consumption; over 6–18 months, validate fab/backend execution and returns on capacity. No valuation or current price is provided, so avoid a price-target-driven chase.

Key Decisions for Investors

• For an existing VSH position, hold and reassess on Q4 results; add only on weakness if end-customer POS remains firm and gross margin meets or exceeds the guided range. A miss on either would weaken the operating-leverage thesis.
• Treat book-to-bill and backlog as watch signals, not standalone buy triggers. Reduce exposure if POS decelerates while distributor inventory rises, or if lead times extend without corresponding margin improvement—evidence that orders may be running ahead of consumption or capacity.
• Track Germany fab commissioning and backend plans through 2027 before capitalizing projected capacity benefits. Further slippage or rising capex without improved utilization would challenge the structural-margin thesis; verify full-year cash flow after the receivables-securitization reduction rather than extrapolating one strong quarter.